WF International Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

PR Newswire

CHENGDU, China, Dec. 30, 2025 /PRNewswire/ —  WF International Limited (the “Company” or “WF International”) (NASDAQ: WXM), an integrated electromechanical solutions company specializing in the supply, installation, fitting-out, and maintenance of HVAC systems, floor heating systems, and water purification systems, today announced that the Company had received a notification letter (the “Notification Letter”) dated December 24, 2025 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifiying the Company that it is not currently in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2), because the closing bid price of the Company’s ordinary shares, par value $0.000001 per share, was below $1.00 per share for a period of 33 consecutive business days from November 6, 2025, to December 23, 2025.

The Notification Letter has no immediate effect on the listing of the Company’s ordinary shares, which will continue to trade uninterrupted on Nasdaq under the ticker “WXM”.

Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until June 22, 2026 (the “Compliance Period”), to regain compliance with Nasdaq’s minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per share of the Company’s ordinary shares is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed.

In the event the Company does not regain compliance with the minimum bid price requirement by June 22, 2026, the Company may be eligible for an additional 180 calendar day grace period. To qualify, the Company will be required to meet the continued listing requirement for all other initial listing standards for the Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split, if necessary.

About WF International Limited

WF International Limited specializes in the supply, installation, fitting-out, and maintenance services for HVAC systems, floor heating systems, and water purification systems. With extensive experience serving commercial projects and high-end residential projects throughout Sichuan, China, the Company has established itself as a trusted provider of premium electromechanical solutions.

The Company’s portfolio includes installations for HVAC projects such as the International Finance Squares across China, Chengdu Vanke Charm City, Chengdu Raffles Plaza, Chengdu Yinshi Plaza, Chengdu Metro No. Ten Line, and Panzhihua Jinhai Hotel.

Since 2017, WF International has expanded its service offerings to include comprehensive heating and water purification solutions, positioning itself as an integrated supplier of both electromechanical products and installation services for large-scale commercial projects and real estate developer clients that offer high-end fully furnished homes. For more information, please visit the Company’s website at https://wf.international.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company’s anticipated use of proceeds of this Offering. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “likely,” “potential,” and “continue.” These statements are based on current expectations and projections about future events that may affect our financial condition, results of operations, business strategy, and financial needs. Actual results may differ materially due to risks and uncertainties, including those in the “Risk Factors” section in the Company’s Annual Report on Form 20-F for the fiscal year ended September 30, 2024, filed with the SEC on February 3, 2025 and prospecus for the Company’s initial public offering, filed with the SEC on April 1, 2025. These factors include, but are not limited to: the uncertainties related to market conditions, industry growth and competition, supplier and customer dependencies, project execution capabilities, expansion plans, economic and political conditions, and technological changes. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Investors should not place undue reliance on forward-looking statements. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: [email protected]

Cision View original content:https://www.prnewswire.com/news-releases/wf-international-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency-302650894.html

SOURCE WF International Limited

reAlpha (Nasdaq: AIRE) Announces National Loan Officer Recruitment Program with RSU Incentives

Program aligns performance-based equity incentives with internal leads, training support, and AI-enabled tools to support reAlpha Mortgage’s national expansion

DUBLIN, Ohio, Dec. 30, 2025 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced that reAlpha Mortgage, its mortgage division, has launched a national Loan Officer Recruitment Program, which offers Restricted Stock Unit (“RSU”) awards to loan officers who join reAlpha. The program issues RSUs pursuant to the Company’s existing equity incentive plan (as amended, the “EIP”) and is designed to attract experienced, high-producing residential mortgage loan officers across the United States.

The program introduces a more consistent recruiting and onboarding framework and pairs performance-aligned incentives with operational support, intentionally designed to help Loan Officers spend less time navigating process and more time focused on production and borrowers.

Under the program, eligible originators with verified trailing twelve-month production may qualify for RSUs in reAlpha’s common stock, which vest over 4 years, are contingent on continued employment at reAlpha and subject to other conditions more fully described in the Company’s EIP and the applicable award agreements.

reAlpha Mortgage provides its Loan Officers with access to in-house lead sources, onboarding and product training (including specialized support for VA lending), and operational systems designed to reduce administrative friction. Loan officers also have access to reAlpha’s internal AI Loan Officer Assistant, which is designed to streamline document workflows and task organization, and the Company’s internal AI-powered Engagement Assistant, built to strengthen lead engagement, qualification, and follow-up so originators can focus on customer-facing activities.

“Loan officers don’t need another recruiting pitch: they need a platform that reduces the administrative load and respects the value of their contribution,” said Jamie Cavanaugh, Chief Executive Officer of reAlpha Mortgage. “This program was built around what experienced originators consistently ask for: clarity, support, and fewer operational obstacles. reAlpha Mortgage is structured to offer eligible Loan Officers the opportunity to participate through an equity incentive program in a publicly traded technology company. When paired with internal leads, training, and AI-enabled tools, we’re focused on creating an environment where originators can spend more time with customers and less time managing complexity. We believe this program will accelerate our national mortgage buildout into 2026.”

The program aligns with reAlpha Mortgage’s broader objectives to strengthen its national infrastructure, support consistent onboarding practices, and reinforce operational readiness as the division continues to expand across its licensed markets.

For more information or to express interest, visit www.realpha.com/mortgage/hiring.

About reAlpha Tech Corp.

reAlpha Tech Corp. (Nasdaq: AIRE) is an AI-powered real estate technology company that aims to transform the multi-trillion-dollar U.S. real estate services market. reAlpha is developing an end-to-end platform that streamlines real estate transactions through integrated brokerage, mortgage, and title services. With a strategic, acquisition-driven growth model and proprietary AI infrastructure, reAlpha is building a vertically integrated ecosystem designed to deliver a simpler, smarter, and more affordable path to homeownership. For more information, visit www.realpha.com.

Not an Offer to Buy or Sell Securities

This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would require preparation of a prospectus or other offer documentation, or be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. Any offers or sales of securities will be made only pursuant to an effective registration statement and applicable prospectus.

Forward-Looking Statements

The information in this press release includes “forward-looking statements.” Any statements other than statements of historical fact contained herein, including statements by Chief Executive Officer of reAlpha Mortgage, Jamie Cavanaugh, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “could”, “might”, “plan”, “possible”, “project”, “strive”, “budget”, “forecast”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: reAlpha’s ability to enhance its operational efficiency, improve cross-functional coordination and support the reAlpha platform’s continued growth through the implementation of its new internal organizational structure; reAlpha’s ability to scale its operational capabilities to expand into additional geographic markets and nationally; reAlpha’s ability to commercialize its developing AI-based technologies; reAlpha’s ability to pay contractual obligations; reAlpha’s liquidity, operating performance, cash flow and ability to secure future financing on favorable terms if needed; reAlpha’s limited operating history and that reAlpha has not yet fully developed its AI-based technologies; whether reAlpha’s technology and products will be accepted and adopted by its customers and intended users; the potential loss of key employees of reAlpha and of its subsidiaries; the outcome of certain outstanding legal proceedings against reAlpha and any legal proceedings that might be instituted against reAlpha; reAlpha’s ability to obtain, and maintain, the required licenses to operate in the U.S. states in which it, or its subsidiaries, operate in, or intend to operate in; reAlpha’s ability to maintain and strengthen its brand and reputation; reAlpha’s ability to benefit from the implementation and use of its internal AI-powered assistants; reAlpha’s ability to regain compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) during the additional compliance period; reAlpha’s ability to maintain compliance with additional applicable Nasdaq listing rules; any accidents or incidents involving cybersecurity breaches and incidents; the availability of rebates, which may be limited or restricted by state law; risks specific to AI-based technologies, including potential inaccuracies, bias, or regulatory restrictions; risks related to data privacy, including evolving laws and consumer expectations; reAlpha’s ability to accurately forecast demand for AI-based real estate-focused products; reAlpha’s ability to execute business objectives and growth strategies successfully or sustain reAlpha’s growth; changes in applicable laws or regulations, and the impact of the regulatory environment and complexities with compliance related to such environment; and other risks and uncertainties indicated in reAlpha’s SEC filings. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. Although reAlpha believes that the expectations reflected in the forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. reAlpha’s future results, level of activity, performance or achievements may differ materially from those contemplated, expressed or implied by the forward-looking statements, and there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking statements. For more information about the factors that could cause such differences, please refer to reAlpha’s filings with the SEC. Readers are cautioned not to put undue reliance on forward-looking statements, and reAlpha does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Media Contact:

Cristol Rippe, Chief Marketing Officer


[email protected]

Investor Relations Contact:

Adele Carey, VP of Investor Relations


[email protected]



Sandisk to Report Fiscal Second Quarter Results on January 29, 2026

Sandisk to Report Fiscal Second Quarter Results on January 29, 2026

MILPITAS, Calif.–(BUSINESS WIRE)–
Sandisk Corporation (NASDAQ: SNDK) announced today that it will hold its fiscal second quarter earnings conference call on Thursday, January 29, 2026, at 1:30 p.m. Pacific Time.

A live webcast and a webcast replay of the conference call will be available at investor.sandisk.com.

About Sandisk

Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and the moment, enabling them to keep moving and pushing possibility forward. Follow Sandisk on Instagram, Facebook, X, LinkedIn, YouTube. Join TeamSandisk on Instagram.

Sandisk and the Sandisk logo are registered trademarks or trademarks of Sandisk Corporation or its affiliates in the U.S. and/or other countries.

© 2025 Sandisk Corporation or its affiliates. All rights reserved.

Company Contacts:

Investors: [email protected]

Media: [email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Semiconductor Data Management Consumer Electronics Technology Other Technology Hardware

MEDIA:

Logo
Logo

Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2025

TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) — TEL-AVIV, Israel, Dec. 30, 2025 (GLOBE NEWSWIRE) — Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and the USA, today reported its unaudited interim consolidated financial results for the three and nine month periods ended September 30, 2025.

Financial Highlights

  • Total assets as of September 30, 2025 amounted to approximately €759.4 million, compared to total assets as of December 31, 2024 of approximately €677.3 million.
  • Revenues1 for the three months ended September 30, 2025 were approximately €12.7 million, compared to revenues of approximately €12.3 million for the three months ended September 30, 2024. Revenues for the nine months ended September 30, 2025 were approximately €32.9 million, compared to revenues of approximately €31.8 million for the nine months ended September 30, 2024.
  • Profit for the three months ended September 30, 2025 was approximately €10.1 million, compared to profit of approximately €6.6 million for the three months ended September 30, 2024. Profit for the nine months ended September 30, 2025 was approximately €8.5 million, compared to profit of approximately €3.3 million for the nine months ended September 30, 2024.
  • EBITDA for the three months ended September 30, 2025 was approximately €22.1 million, compared to EBITDA of approximately €11 million for the three months ended September 30, 2024. EBITDA for the nine months ended September 30, 2025 was approximately €28.2 million, compared to EBITDA of approximately €17.6 million for the nine months ended September 30, 2024. See below under “Use of Non-IFRS Financial Measures” for additional disclosure concerning EBITDA.

Financial Overview for the Nine Months Ended September 30, 2025

  • Revenues1 were approximately €32.9 million for the nine months ended September 30, 2025, compared to approximately €31.8 million for the nine months ended September 30, 2024. The increase in revenues mainly results from revenues generated from the Company’s 19.8 MW and 18.1 MW Italian solar facilities that were connected to the grid in February-May 2024 and in January 2025, respectively, and from the Company’s facilities in the USA that were connected to the grid during the second quarter of 2025. Such increase was partly offset by lower revenues from the Company’s Dutch biogas plants, one of which experienced a production issue related to the bacteria used by the plant that affected output in January and April 2025 and another facility whose output was adversely affected during the summer months due to high temperatures. In addition, revenues from the Talasol facility were slightly lower in the nine months ended September 30, 2025, due to damage caused by a fire event that occurred in July 2024, that has since been repaired and restored to nearly 97% output, though not yet fully recovered.
  • Operating expenses were approximately €14.4 million for the nine months ended September 30, 2025, compared to approximately €14.5 million for the nine months ended September 30, 2024. The decrease in operating expenses mainly results from lower costs in connection with the acquisition of feedstock by the Company’s Dutch biogas plants, partially offset by the achievement of preliminary acceptance certificate (PAC) of the Company’s 19.8 MW Italian solar facilities subsequent to September 30, 2024, upon which the Company commenced recording operating expenses of the solar facilities. Depreciation and amortization expenses were approximately €12.9 million for the nine months ended September 30, 2025, compared to approximately €12.3 million for the nine months ended September 30, 2024.
  • Project development costs were approximately €3.4 million for the nine months ended September 30, 2025, compared to approximately €3.3 million for the nine months ended September 30, 2024.
  • General and administrative expenses were approximately €5.2 million for the nine months ended September 30, 2025, compared to approximately €4.7 million for the nine months ended September 30, 2024. The increase in general and administrative expenses is mostly due to higher consultancy expenses.
  • Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €17 million for the nine months ended September 30, 2025, compared to approximately €5.3 million for the nine months ended September 30, 2024. The increase in share of profits of equity accounted investee was mainly due to the recording of a gain on bargain purchase by Ellomay Luzon Energy Infrastructures Ltd. (“Ellomay Luzon Energy”), an equity accounted investee of the Company, in the amount of NIS 112.8 million (approximately €28.7 million based on the average EUR/USD exchange rate for the year 2025) in connection with the acquisition on July 22, 2025 of 15% of the outstanding share capital of Dorad Energy Ltd. (“Dorad”) by Ellomay Luzon Energy reflecting the excess of the net amount recognized at the acquisition date for the identifiable assets over the cost of the acquired Dorad shares.
  • Other income, net was approximately €1.3 million for the nine months ended September 30, 2025, compared to €2.9 for the nine months ended September 30, 2024. The other income recognized for the nine months ended September 30, 2025 is based on agreed compensation expected to be received from the EPC contractor of two of the Company’s USA solar facilities for loss of income due to delays in construction and the other income recognized for the nine months ended September 30, 2024 is based on compensation received from insurance in connection with the fire near the Talasol and Ellomay Solar facilities in Spain in July 2024, net of impairment expenses related to the damaged fixed assets.
  • Financing expense, net was approximately €8.7 million for the nine months ended September 30, 2025, compared to financing expense, net of approximately €2 million for the nine months ended September 30, 2024. The change in financing expenses, net, was mainly attributable to lower income resulting from exchange rate differences that amounted to approximately €1.6 million for the nine months ended September 30, 2025, compared to approximately €5.2 million for the nine months ended September 30, 2024, an aggregate change of approximately €3.5 million. The exchange rate differences were mainly recorded in connection with the New Israeli Shekel (“NIS”) cash and cash equivalents and the Company’s NIS denominated debentures and were caused by the 2.2% devaluation of the NIS against the euro during the nine months ended September 30, 2025, compared to 3.5% devaluation of the NIS against the euro during the nine months ended September 30, 2024. The increase in financing expense for the nine months ended September 30, 2025 was also attributable to an increase in financing expense of approximately €3.4 million in connection with derivatives and warrants for the nine months ended September 30, 2025, compared to the nine months ended September 30, 2024. The increase was partially offset by increased interest income on balances mainly deposited by the Company for short-term periods.
  • Tax benefit was approximately €1.8 million for the nine months ended September 30, 2025, compared to a tax benefit of approximately €0.1 million for the nine months ended September 30, 2024. The change is primarily attributable to the tax impact of the investment transaction with Clal Insurance Company Ltd. (“Clal”) in the Company’s 198 MW solar portfolio, which is expected to be fully offset through the utilization of current losses.
  • Profit for the nine months ended September 30, 2025 was approximately €8.5 million, compared to a profit of approximately €3.3 million for the nine months ended September 30, 2024.
  • Total other comprehensive loss was approximately €8.6 million for the nine months ended September 30, 2025, compared to total other comprehensive income of approximately €2.6 million for the nine months ended September 30, 2024. The change in total other comprehensive income (loss) is primarily as the result of foreign currency translation adjustments due to the change in the NIS/euro exchange rate and by changes in fair value of cash flow hedges, including a material decrease in the fair value of the liability resulting from the financial power swap that covers approximately 80% of the output of the Talasol solar plant (the “Talasol PPA”). The Talasol PPA experienced high volatility due to the substantial change in electricity prices in Europe. In accordance with hedge accounting standards, the changes in the Talasol PPA’s fair value are recorded in the Company’s shareholders’ equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows.
  • Total comprehensive loss was approximately €0.1 million for the nine months ended September 30, 2025, compared to total comprehensive income of approximately €5.9 million for the nine months ended September 30, 2024.
  • Net cash provided by operating activities was approximately €8.5 million for the nine months ended September 30, 2025, compared to approximately €5.5 million for the nine months ended September 30, 2024. The increase in net cash provided by operating activities for the nine months ended September 30, 2025, is mainly due to income produced by the Company’s Italian solar facilities that were connected to the grid in February-May 2024 and in January 2025, three of the Company’s facilities in Texas USA that were connected to the grid and commenced commissioning tests in April 2024, and 2024 related subsidies that were paid to the Company’s Dutch biogas plants in 2025.
  • In September 2025, the Company received tax credits in respect of two facilities in the USA in an aggregate amount of approximately €10 million, which were presented as cash flows provided by financing activities.
1 The revenues presented in the Company’s financial results included in this press release are based on IFRS and do not take into account the adjustments included in the Company’s investor presentation.



CEO Review for the First Nine Months of 2025

In the first nine months, the Company’s revenues amounted to approximately €32.9 million, an increase of approximately 3% in revenues compared to the corresponding period last year. Cash provided by operating activities was approximately €8.5 million in the first nine months compared to approximately €5.5 million in the corresponding period last year. The EBITDA for the first nine months of 2025 was approximately €28.2 million, compared to approximately €17.6 million in the corresponding period last year.

In the first nine months of 2025, there was a significant advancement in the construction and connection to the grid of new projects, which are expected to contribute to a significant increase in the Company’s revenues during 2026.

In Italy – 38 MW solar (51% owned in partnership with Clal) are fully operating. The construction work on additional 160 MW solar (51% owned in partnership with Clal) has begun and construction is progressing as planned and is expected to finish by the end of 2026. The remainder of the portfolio developed by the Company (100% owned) is approximately 264 MW solar, of which 210 MW have reached Ready to Build status as of the date hereof and the rest are expected to receive permits in the near future. These 264 MW are scheduled to begin construction in the last quarter of 2026. The Company signed a power purchase agreement (PPA) with a leading European entity for the operating projects with an aggregate capacity of 38 MW and the Company intends to continue to execute PPAs for the remainder of the portfolio.

In the USA – The construction of the first 4 projects (49 MW) has been completed, three of them were connected to the grid at the end of the first half of 2025 and the fourth project will be connected in the near future. The Company has begun construction of the Hillsboro project (14 MW solar + two hours of battery storage). The Company is examining the possibility of entering into the construction of two additional projects that will fall within the current tax benefit framework. The regulatory changes and the uncertainty regarding tariff rates do not allow the Company to provide a forecast beyond what has been said, but the assumption is that the Company will find a way to continue developing and increasing the portfolio in the near future.

In the Netherlands – the license to increase production at the GGOT facility was received. Licenses to increase production at the two additional facilities are in advanced stages. The new regulation for the obligation to blend green gas with fossil gas will commence according to the law in January 2027 (a delay of one year), but the targets for the first year have increased. Agreements have been signed for the sale of green certificates issued under the new regulation at a price of approximately €1 per certificate. The blending obligation is expected to significantly increase the profitability of operations in the Netherlands at current production capacity. The expected increase in production capacity from 16 million cubic meters of gas per year to around 24 million cubic meters of gas per year is expected to add significantly beyond that.

In Israel – the Company is in negotiations with the Israeli Electricity Authority for compensation for delays and war damage to the Manara project. Ellomay Luzon (50% owned) exercised its right of refusal in connection with the Zorlu-Phoenix transaction for the sale of Dorad’s shares and acquired an additional 15% of Dorad’s shares so that its holdings in Dorad are currently 33.75%. Dorad notified of the approval of its board of directors to advance to financial closing of Dorad 2 and the intention is to try to reach financial closing by June 30, 2026.

Dorad finished the third quarter with a profit of approximately NIS 118.4 million, despite a decline of approximately 10% in the USD exchange rate, which caused an accounting expense during the period of approximately NIS 69 million on Dorad’s USD deposits. Dorad has future expenses in USD (gas purchases, operation and maintenance payments, construction of Dorad 2) that constitute a natural hedge for the USD deposits. Dorad is actively advancing the establishment of the Dorad 2 project (an expansion of the existing power station using an H-type turbine with a generation capacity of approximately 700 MWh).

In Spain – The Company’s development activity in Spain focuses on energy storage in batteries, whereby the process for obtaining license for Ellomay Solar (28 MWp for two hours of battery storage) is in advanced stages and is expected to be received in the coming months. In addition, the Company is advancing a battery storage project for Talasol (120 MWp). The high volatility in electricity prices in Spain stems from an excess of renewable energy during the transition seasons and causes damage to the stability of the grid. In the Company’s assessment, the solution is a significant increase in storage capacity, which is currently at very low levels in Spain.

Use of Non-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company’s operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company’s commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company’s EBITDA may not be indicative of the Company’s historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company’s operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 14 of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe, USA and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy, Spain, the Netherlands and Texas, USA, including:

  • Approximately 335.9 MW of operating solar power plants in Spain (including a 300 MW solar plant in owned by Talasol, which is 51% owned by the Company) and 51% of approximately 38 MW of operating solar power plants in Italy;
  • 16.875% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel’s largest private power plants with production capacity of approximately 850 MW;
  • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million Nm3 per year, respectively;
  • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel;
  • 51% of solar projects in Italy with an aggregate capacity of 160 MW that are under construction;
  • Solar projects in Italy with an aggregate capacity of 210 MW that have reached “ready to build” status; and
  • Solar projects in the Dallas Metropolitan area, Texas, USA with an aggregate capacity of approximately 38 MW that are connected to the grid and additional 11 MW that are awaiting connection to the grid.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including changes in electricity prices and demand, regulatory changes increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, the impact of the war and hostilities in Israel and Gaza and between Israel and Iran, the outcome of legal proceedings in connection with Dorad Energy Ltd., technical and other disruptions in the operations or construction of the power plants owned by the Company, inability to obtain the financing required for the development and construction of projects, inability to advance the expansion of Dorad, increases in interest rates and inflation, changes in exchange rates, delays in development, construction, or commencement of operation of the projects under development, failure to obtain permits – whether within the set time frame or at all, climate change, the impact of the continued military conflict between Russia and Ukraine, and general market, political and economic conditions in the countries in which the Company operates, including Israel, Spain, Italy and the United States. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: [email protected]

Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Financial Position  
   
    September 30,     December 31,     September 30,  
    2025     2024     2025  
    € in thousands     Convenience Translation into US$ in thousands*  
Assets                  
Current assets:                  
Cash and cash equivalents     49,288       41,134       57,856  
Restricted cash     656       656       770  
Intangible asset from green certificates     419       178       492  
Trade and revenue receivables     5,461       5,393       6,410  
Other receivables     15,212       15,341       17,856  
Derivatives asset short-term     250       146       293  
Other receivables – investment transaction     4,221             4,955  
      75,507       62,848       88,632  
Non-current assets                        
Investment in equity accounted investee     57,545       41,324       67,548  
Advances on account of investments           547        
Fixed assets     528,851       482,747       620,784  
Right-of-use asset     41,579       34,315       48,807  
Restricted cash and deposits     15,940       17,052       18,711  
Deferred tax     11,276       9,039       13,236  
Long-term receivables     16,212       13,411       19,030  
Derivatives     12,534       15,974       14,713  
      683,937       614,409       802,829  
Total assets     759,444       677,257       891,461  
                         
Liabilities and Equity                        
Current liabilities                        
Short-term bank loans and current maturities of long-term bank loans     16,133       21,316       18,937  
Current maturities of other long-term loans     3,666       5,866       4,303  
Current maturities of debentures     12,013       35,706       14,101  
Trade payables     11,995       8,856       14,080  
Other payables     16,533       10,896       19,407  
Current maturities of derivatives     237       1,875       278  
Current maturities of lease liabilities     814       714       956  
Warrants     2,507       1,446       2,943  
      63,898       86,675       75,005  
Non-current liabilities                        
Long-term lease liabilities     33,304       25,324       39,093  
Long-term bank loans     243,627       245,866       285,978  
Other long-term loans     42,788       30,448       50,226  
Debentures     194,575       155,823       228,399  
Deferred tax     2,621       2,609       3,077  
Other long-term liabilities     8,186       939       9,609  
Derivatives     1,353       288       1,588  
      526,454       461,297       617,970  
Total liabilities     590,352       547,972       692,975  
                         
Equity                        
Share capital     27,998       25,613       32,865  
Share premium     96,568       86,271       113,355  
Treasury shares     (1,736 )     (1,736 )     (2,038 )
Transaction reserve with non-controlling interests     14,757       5,697       17,322  
Reserves     6,764       14,338       7,940  
Accumulated deficit     (1,123 )     (11,561 )     (1,318 )
Total equity attributed to shareholders of the Company     143,228       118,622       168,126  
Non-controlling interest     25,864       10,663       30,360  
Total equity     169,092       129,285       198,486  
Total liabilities and equity     759,444       677,257       891,461  

* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)
   

Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Comprehensive Income  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended December 31,     For the nine months ended September 30,  
    2025     2024     2025     2024     2024     2025  
    Unaudited     Audited     Unaudited  
    € in thousands (except per share data)     Convenience Translation into US$*  
Revenues     12,729       12,333       32,865       31,789       40,467       38,578  
Operating expenses     (5,155 )     (4,982 )     (14,361 )     (14,505 )     (19,803 )     (16,857 )
Depreciation and amortization expenses     (4,362 )     (4,111 )     (12,850 )     (12,342 )     (15,887 )     (15,084 )
Gross profit     3,212       3,240       5,654       4,942       4,777       6,637  
                                                 
Project development costs     (511 )     (1,030 )     (3,381 )     (3,311 )     (4,101 )     (3,969 )
General and administrative expenses     (1,781 )     (1,645 )     (5,165 )     (4,679 )     (6,063 )     (6,063 )
Share of profits of equity accounted investee     16,999       3,486       17,011       5,295       11,062       19,968  
Other income (expenses), net     (153 )     2,885       1,278       2,885       3,409       1,500  
Operating profit     17,766       6,936       15,397       5,132       9,084       18,073  
                                                 
Financing income     7,853       4,553       9,596       6,977       2,495       11,264  
Financing income (expenses) in connection with derivatives and warrants, net     (1,037 )     (90 )     (599 )     2,762       1,140       (703 )
Financing expenses in connection with projects finance     (1,928 )     (1,693 )     (5,016 )     (4,646 )     (6,190 )     (5,888 )
Financing expenses in connection with debentures     (971 )     (1,486 )     (4,971 )     (5,048 )     (6,641 )     (5,835 )
Interest expenses on minority shareholder loan     (424 )     (528 )     (1,355 )     (1,616 )     (2,144 )     (1,591 )
Other financing expenses     (11,209 )     (145 )     (6,349 )     (428 )     (8,311 )     (7,453 )
Financing income (expenses), net     (7,716 )     611       (8,694 )     (1,999 )     (19,651 )     (10,206 )
                                                 
Profit before taxes on income     10,050       7,547       6,703       3,133       (10,567 )     7,867  
Tax benefit (taxes on income)     19       (916 )     1,790       72       1,424       2,101  
Profit (loss) for the period from continuing operations     10,069       6,631       8,493       3,205       (9,143 )     9,968  
Profit from discontinued operation (net of tax)                       79       137        
Profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Profit (loss) attributable to:                                                
Owners of the Company     10,128       6,104       10,438       4,670       (6,524 )     12,252  
Non-controlling interests     (59 )     527       (1,945 )     (1,386 )     (2,482 )     (2,284 )
Profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Other comprehensive income (loss) item that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss:                                                
Foreign currency translation differences for foreign operations     2,911       (4,719 )     (6,137 )     (5,152 )     8,007       (7,204 )
Foreign currency translation differences for foreign operations that were recognized in profit or loss                       255       255        
Effective portion of change in fair value of cash flow hedges     (2,248 )     286       386       9,412       5,631       453  
Net change in fair value of cash flow hedges transferred to profit or loss     (539 )     1,363       (2,821 )     (1,921 )     (813 )     (3,312 )
Total other comprehensive income (loss)     124       (3,070 )     (8,572 )     2,594       13,080       (10,063 )
                                                 
Total other comprehensive income (loss) attributable to:                                                
Owners of the Company     1,281       (4,020 )     (7,574 )     (1,315 )     10,039       (8,891 )
Non-controlling interests     (1,157 )     950       (998 )     3,909       3,041       (1,172 )
Total other comprehensive income (loss) for the period     124       (3,070 )     (8,572 )     2,594       13,080       (10,063 )
Total comprehensive income (loss) for the period     10,193       3,561       (79 )     5,878       4,074       (95 )
                                                 
Total comprehensive income (loss) attributable to:                                                
Owners of the Company     11,409       2,084       2,864       3,355       3,515       3,361  
Non-controlling interests     (1,216 )     1,477       (2,943 )     2,523       559       (3,456 )
Total comprehensive income (loss) for the period     10,193       3,561       (79 )     5,878       4,074       (95 )

* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US $ 1.174)
   

Ellomay Capital Ltd. and its Subsidiaries  
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income (cont’d)  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended

December 31,
    For the nine months ended

September 30,
 
    2025     2024     2025     2024     2024     2025  
    Unaudited     Audited     Unaudited  
    € in thousands (except per share data)     Convenience Translation into US$*  
Basic profit (loss) per share     0.79       0.47       0.81       0.36       (0.51 )     0.95  
Diluted profit (loss) per share     0.79       0.47       0.81       0.36       (0.51 )     0.95  
                                                 
Basic profit (loss) per share continuing operations     0.79       0.47       0.81       0.35       (0.52 )     0.95  
Diluted profit (loss) per share continuing operations     0.79       0.47       0.81       0.35       (0.52 )     0.95  
                                                 
Basic profit per share discontinued operation                       0.01       0.01        
Diluted profit per share discontinued operation                       0.01       0.01        

* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)
   

Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Changes in Equity  
   
                Attributable to shareholders of the Company     Non- controlling Interests     Total Equity  
    Share capital     Share premium     Retained earnings (accumulated Deficit)     Treasury shares     Translation reserve from foreign operations     Hedging Reserve     Transaction reserve with non-controlling interests     Total              
    € in thousands  
For the nine months ended September 30, 2025 (unaudited):                                                            
Balance as at January 1, 2025     25,613       86,271       (11,561 )     (1,736 )     8,446       5,892       5,697       118,622       10,663       129,285  
Profit for the period                     10,438                                       10,438       (1,945 )     8,493  
Other comprehensive loss for the period                                   (6,220 )     (1,354 )             (7,574 )     (998 )     (8,572 )
Total comprehensive loss for the period                 10,438             (6,220 )     (1,354 )           2,864       (2,943 )     (79 )
Transactions with owners of the Company, recognized directly in equity:                                                                                
Sale of shares in subsidiaries from non-controlling interests                                         9,060       9,060       16,997       26,057  
Options exercise     3       5                                     8             8  
Issuance of ordinary shares     2,382       10,281                                     12,663             12,663  
Issuance of capital note to non-controlling interest                                                     1,147       1,147  
Share-based payments           11                                     11             11  
Balance as at September 30, 2025     27,998       96,568       (1,123 )     (1,736 )     2,226       4,538       14,757       143,228       25,864       169,092  
                                                                                 
For the nine months ended September 30, 2024 (unaudited):                                                                                
Balance as at January 1, 2024     25,613       86,159       (5,037 )     (1,736 )     385       3,914       5,697       114,995       10,104       125,099  
Profit (loss) for the period                 4,670                               4,670       (1,386 )     3,284  
Other comprehensive income (loss) for the period                             (4,762 )     3,447             (1,315 )     3,909       2,594  
Total comprehensive income (loss) for the period                 4,670             (4,762 )     3,447             3,355       2,523       5,878  
Transactions with owners of the Company, recognized directly in equity:                                                                                
Share-based payments           91                                     91             91  
Balance as at September 30, 2024     25,613       86,250       (367 )     (1,736 )     (4,377 )     7,361       5,697       118,441       12,627       131,068  

   
Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Changes in Equity (cont’d)  
   
                Attributable to shareholders of the Company     Non- controlling Interests     Total Equity  
    Share capital     Share premium     Accumulated deficit     Treasury shares     Translation reserve from foreign operations     Hedging Reserve     Transaction reserve with non-controlling interests     Total              
    € in thousands  
For the year ended December 31, 2024 (audited):                                                            
Balance as at January 1, 2024     25,613       86,159       (5,037 )     (1,736 )     385       3,914       5,697       114,995       10,104       125,099  
Loss for the year                 (6,524 )                             (6,524 )     (2,482 )     (9,006 )
Other comprehensive income for the year                             8,061       1,978             10,039       3,041       13,080  
Total comprehensive income (loss) for the year                 (6,524 )           8,061       1,978             3,515       559       4,074  
Transactions with owners of the Company, recognized directly in equity:                                                                                
Share-based payments           112                                     112             112  
Balance as at December 31, 2024     25,613       86,271       (11,561 )     (1,736 )     8,446       5,892       5,697       118,622       10,663       129,285  

   
Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Changes in Equity (cont’d)  
   
                Attributable to shareholders of the Company     Non- controlling Interests     Total Equity  
    Share capital     Share premium     Accumulated deficit     Treasury shares     Translation reserve from foreign operations     Hedging Reserve     Transaction reserve with non-controlling interests     Total              
    Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$1.174)  
For the nine months ended September 30, 2025 (unaudited):                                                            
Balance as at January 1, 2025     30,065       101,268       (13,570 )     (2,038 )     9,915       6,916       6,687       139,243       12,518       151,761  
Profit for the period                 12,252                               12,252       (2,284 )     9,968  
Other comprehensive loss for the period                             (7,301 )     (1,590 )           (8,891 )     (1,172 )     (10,063 )
Total comprehensive loss for the period                 12,252             (7,301 )     (1,590 )           3,361       (3,456 )     (95 )
Transactions with owners of the Company, recognized directly in equity:                                                                                
Sale of shares in subsidiaries from non-controlling interests                                         10,635       10,635       19,952       30,587  
Options exercise     4       6                                     10             10  
Issuance of ordinary shares     2,796       12,068                                     14,864             14,864  
Issuance of capital note to non-controlling interest                                                     1,346       1,346  
Share-based payments           13                                     13             13  
Balance as at September 30, 2025     32,865       113,355       (1,318 )     (2,038 )     2,614       5,326       17,322       168,126       30,360       198,486  

   
Ellomay Capital Ltd. and its Subsidiaries  
Unaudited Condensed Consolidated Interim Statements of Cash Flow  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended December 31,     For the nine months ended September 30,  
    2025     2024     2025     2024     2024     2025  
    € in thousands     Convenience Translation into US$*  
Cash flows from operating activities                                    
Profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Adjustments for:                                                
Financing income (expenses), net     7,716       (611 )     8,694       1,595       19,247       10,206  
Profit (loss) from settlement of derivatives contract           (149 )           50       316        
Impairment losses on assets of disposal groups classified as held-for-sale                       405       405        
Depreciation and amortization     4,362       4,111       12,850       12,390       15,935       15,084  
Share-based payment transactions     7       30       11       91       112       13  
Share of profits of equity accounted investees     (16,999 )     (3,486 )     (17,011 )     (5,295 )     (11,062 )     (19,968 )
Change in trade receivables and other receivables     (1,083 )     (4 )     6,302       (3,218 )     (8,824 )     7,398  
Change in other assets     469       871       (533 )     876       3,770       (626 )
Change in receivables from concessions project                       793       793        
Change in trade payables     (501 )     554       2,177       (79 )     (31 )     2,555  
Change in other payables     1,293       (2,052 )     (3,517 )     (293 )     4,455       (4,128 )
Income tax expense (tax benefit)     (19 )     916       (1,790 )     (77 )     (1,429 )     (2,101 )
Income taxes refund (paid)     7       (133 )     (20 )     346       623       (23 )
Interest received     878       226       2,222       1,932       2,537       2,608  
Interest paid     (2,721 )     (1,827 )     (9,347 )     (7,255 )     (9,873 )     (10,972 )
      (6,591 )     (1,554 )     38       2,261       16,974       46  
Net cash provided by operating activities     3,478       5,077       8,531       5,545       7,968       10,014  
                                                 
Cash flows from investing activities                                                
Acquisition of fixed assets     (22,106 )     (30,453 )     (59,036 )     (50,046 )     (72,922 )     (69,299 )
Interest paid capitalized to fixed assets     (2,071 )     (507 )     (3,898 )     (1,628 )     (2,515 )     (4,576 )
Proceeds from sale of investments                       9,267       9,267        
Advances on account of investments     547       (109 )     547       (163 )     (163 )     642  
Proceeds from advances on account of investments                             514        
Proceeds from (investment in) settlement of derivatives, net           65             224       (316 )      
Proceeds from restricted cash, net     10,530       38       1,364       157       689       1,601  
Proceeds from (investment in) short term deposit           79             (1,404 )     1,004        
Net cash used in investing activities     (13,100 )     (30,887 )     (61,023 )     (43,593 )     (64,442 )     (71,632 )
                                                 
Cash flows from financing activities                                                
Issuance of warrants                 475       3,735       2,449       558  
Cost associated with long-term loans     (1,445 )     (545 )     (2,502 )     (2,011 )     (2,567 )     (2,937 )
Proceeds from option exercise     8             8                   9  
Proceeds from private placement of shares     12,663             12,663                   14,864  
Sale of shares in subsidiaries to non-controlling interests     12,214             33,066                   38,814  
Payment of principal of lease liabilities     (279 )     (179 )     (731 )     (665 )     (2,941 )     (858 )
Proceeds from long and short-term loans     1,129       8,829       19,028       19,307       19,482       22,336  
Repayment of long-term loans     (23,387 )     (441 )     (30,140 )     (7,108 )     (11,776 )     (35,379 )
Repayment of debentures                 (35,691 )     (35,845 )     (35,845 )     (41,895 )
Proceeds from the sale of tax credits     10,160             10,160                   11,926  
Proceeds from issuance of debentures, net           11,966       56,729       57,756       74,159       66,591  
Net cash provided by financing activities     11,063       19,630       63,065       35,169       42,961       74,029  
                                                 
Effect of exchange rate fluctuations on cash and cash equivalents     1,347       (1,408 )     (2,419 )     (220 )     3,092       (2,840 )
Increase (decrease) in cash and cash equivalents     2,788       (7,588 )     8,154       (3,099 )     (10,421 )     9,571  
Cash and cash equivalents at the beginning of the period     46,500       56,044       41,134       51,127       51,127       48,285  
Cash from (used in) disposal groups classified as held-for-sale                       428       428        
Cash and cash equivalents at the end of the period     49,288       48,456       49,288       48,456       41,134       57,856  

* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)
   

  

Ellomay Capital Ltd. and its Subsidiaries  
Operating Segments (Unaudited)  
   
    Italy     Spain     USA     Netherlands     Israel     Total              
          Subsidized     28 MV                                   reportable           Total  
    Solar     Plants     Solar     Talasol     Solar     Biogas     Dorad     Manara     segments     Reconciliations     consolidated  
    For the nine months ended September 30, 2025  
    € in thousands  
                                                                   
Revenues     3,801       2,233       1,171       14,800       542       10,318       50,016             82,881       (50,016 )     32,865  
Operating expenses     (404 )     (394 )     (533 )     (3,604 )     (342 )     (9,085 )     (37,276 )           (51,638 )     37,277       (14,361 )
Depreciation expenses     (674 )     (690 )     (757 )     (8,520 )     (309 )     (1,840 )     (4,026 )           (16,816 )     3,966       (12,850 )
Gross profit (loss)     2,723       1,149       (119 )     2,676       (109 )     (607 )     8,714             14,427       (8,773 )     5,654  
                                                                                         
Project development costs                                                                                     (3,381 )
General and administrative expenses                                                                                     (5,165 )
Share of profit of equity accounted investee                                                                                     17,011  
Other income, net                                                                                     1,278  
Operating profit                                                                                     15,397  
Financing income                                                                                     9,596  
Financing income in connection with derivatives and warrants, net                                                                                     (599 )
Financing expenses in connection with projects finance                                                                                     (5,016 )
Financing expenses in connection with debentures                                                                                     (4,971 )
Interest expenses on minority shareholder loan                                                                                     (1,355 )
Other financing expenses                                                                                     (6,349 )
Financing expenses, net                                                                                     (8,694 )
Profit before taxes on income                                                                                     6,703  
                                                                                         
Segment assets as at September 30, 2025     118,581       12,962       18,919       215,474       72,331       30,083       114,738       191,501       774,589       (15,145 )     759,444  

   
Ellomay Capital Ltd. and its Subsidiaries  
Reconciliation of Profit (Loss) to EBITDA (Unaudited)  
   
    For the three months ended September 30,     For the nine months ended September 30,     For the year ended December 31,     For the nine months ended September 30,  
    2025     2024     2025     2024     2024     2025  
    € in thousands     Convenience Translation into US$ in thousands*  
Net profit (loss) for the period     10,069       6,631       8,493       3,284       (9,006 )     9,968  
Financing (income) expenses, net     7,716       (611 )     8,694       1,999       19,651       10,206  
Taxes on income (Tax benefit)     (19 )     916       (1,790 )     (72 )     (1,424 )     (2,101 )
Depreciation and amortization     4,362       4,111       12,850       12,342       15,887       15,084  
EBITDA     22,128       11,047       28,247       17,553       25,108       33,157  

* Convenience translation into US$ (exchange rate as at September 30, 2025: euro 1 = US$ 1.174)

Ellomay Capital Ltd.
Information for the Company’s Debenture Holders
 

Financial Covenants

Pursuant to the Deeds of Trust governing the Company’s Series D, Series E, Series F and Series G Debentures (together, the “Debentures”), the Company is required to maintain certain financial covenants. For more information, see Items 4.A and 5.B of the Company’s Annual Report on Form 20-F submitted to the Securities and Exchange Commission on April 30, 2025, and below.

Net Financial Debt

As of September 30, 2025, the Company’s Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company’s Debentures), was approximately €164.1 million (consisting of approximately €310.72 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €213.43 million in connection with (i) the Series D Convertible Debentures issuance (in February 2021), (ii) the Series E Secured Debentures issuance (in February 2023), (iii) the Series F Debentures issuance (in January, April, August and November 2024) and (iv) the Series G Debentures issuance (in February 2025)), net of approximately €49.3 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €310.74 million of project finance and related hedging transactions of the Company’s subsidiaries). The Net Financial Debt and other information included in this disclosure do not include the private placement of Series G Debentures consummated in December 2025.

2 The amount of short-term and long-term debt from banks and other interest-bearing financial obligations provided above, includes an amount of approximately €4.3 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company’s balance sheet.
   
3 The amount of the debentures provided above includes an amount of approximately €5.9 million associated costs, which was capitalized and discount or premium and therefore offset from the debentures amount that is recorded in the Company’s balance sheet. This amount also includes the accrued interest as at September 30, 2025 in the amount of approximately €0.9 million.
   
4 The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders’ loans to the project companies).

Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series D Debenture Holders

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €160.2 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.6%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA5 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30,

2025
 
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters6     1,419  
Adjusted EBITDA as defined the Series D Deed of Trust     41,450  

5 The term “Adjusted EBITDA” is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”
   
6 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.

Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series E Debenture Holders

The Deed of Trust governing the Company’s Series E Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series E Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series E Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series E Deed of Trust) was approximately €160.2 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.6%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA7 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series E Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30, 2025  
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters8     1,419  
Adjusted EBITDA as defined the Series E Deed of Trust     41,450  
         

In connection with the undertaking included in Section 3.17.2 of Annex 6 of the Series E Deed of Trust, no circumstances occurred during the reporting period under which the rights to loans provided to Ellomay Luzon Energy Infrastructures Ltd. (formerly U. Dori Energy Infrastructures Ltd. (“Ellomay Luzon Energy”)), if any, which were pledged to the holders of the Company’s Series E Debentures, will become subordinate to the amounts owed by Ellomay Luzon Energy to Israel Discount Bank Ltd.

As of September 30, 2025, the value of the assets pledged to the holders of the Series E Debentures in the Company’s books (unaudited) is approximately €57.5 million (approximately NIS 223.3 million based on the exchange rate as of such date).

7 The term “Adjusted EBITDA” is defined in the Series E Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series E Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series E Deed of Trust). The Series E Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series E Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”
   
8 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.

Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series F Debenture Holders

The Deed of Trust governing the Company’s Series F Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series F Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series F Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series F Deed of Trust) was approximately €159.6 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA9 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series F Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30, 2025  
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters10     1,419  
Adjusted EBITDA as defined the Series F Deed of Trust     41,450  

9 The term “Adjusted EBITDA” is defined in the Series F Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series F Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series F Deed of Trust). The Series F Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series F Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”
   
10 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.

Ellomay Capital Ltd.
Information for the Company’s Debenture Holders (cont’d)
 

Information for the Company’s Series G Debenture Holders

The Deed of Trust governing the Company’s Series G Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series G Deed of Trust is a cause for immediate repayment. As of September 30, 2025, the Company was in compliance with the financial covenants set forth in the Series G Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series G Deed of Trust) was approximately €159.6 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 50.7%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA11 was 4.

The following is a reconciliation between the Company’s profit and the Adjusted EBITDA (as defined in the Series G Deed of Trust) for the four-quarter period ended September 30, 2025:

    For the four-quarter period ended September 30, 2025  
    Unaudited  
    € in thousands  
Profit for the period     7,268  
Financing expenses, net     22,514  
Taxes on income     (2,466 )
Depreciation and amortization expenses     12,711  
Share-based payments     4  
Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters12     1,419  
Adjusted EBITDA as defined the Series G Deed of Trust     41,450  

11 The term “Adjusted EBITDA” is defined in the Series G Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series G Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series G Deed of Trust). The Series G Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series G Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of Non-IFRS Financial Measures.”
   
12 The adjustment is based on the results of a solar plant in Italy and solar plants in the USA that were connected to the grid and commenced delivery of electricity to the grid during the four quarters preceding September 30, 2025. The Company records revenues and only direct expenses in connection with solar plants from the connection to the grid and until preliminary acceptance certificate (PAC). However, for the sake of caution, the Company included the expected fixed expenses in connection with solar plants that have not reached PAC yet in the calculation of the adjustment.



IsoEnergy Acquires Additional Securities in Premier American Uranium Inc.

PR Newswire

TORONTO, Dec. 30, 2025 /PRNewswire/ – IsoEnergy Ltd. (“IsoEnergy”, or the “Company”) (NYSE American: ISOU) (TSX: ISO) is pleased to announce that it has acquired (the “Transaction“) 2,135,760 common shares (the “PUR Common Shares“) of Premier American Uranium Inc. (“PUR“) and warrants to acquire an additional 2,708,627 PUR Shares in consideration for the issuance of an aggregate of 100,000 common shares of the Company (the “ISO Shares“). The ISO Shares were issued at a deemed price of $11.58 per share, representing aggregate consideration of $1,158,000.

Philip Williams, CEO and Director of IsoEnergy, commented, “As a co-founder of PUR in late 2023, we have been impressed by the company’s consistent track record of value creation through disciplined M&A and asset advancement. Against a strengthening uranium price environment and powerful tailwinds in the nuclear sector—particularly in the United States, where PUR is focused—we believe this is an opportune time to increase our equity exposure to the company.”

Immediately prior to the completion of the Transaction, the Company owned an aggregate of 4,245,841 PUR Common Shares and warrants to acquire 167,708 PUR Common Shares, representing approximately 6.27% of the outstanding PUR Common Shares on a non-diluted basis and approximately 6.50% of the outstanding PUR Common Shares on a partially-diluted basis assuming exercise of all of the warrants held by the Company  (before giving effect to the conversion of the compressed shares of PUR (the “Compressed Shares“)). Assuming the conversion of all of the issued and outstanding Compressed Shares into PUR Common Shares, the PUR Common Shares and warrants held by the Company represented approximately 5.38% of the PUR Common Shares on a non-diluted basis and approximately 5.58% of the outstanding PUR Common Shares on partially-diluted basis assuming exercise of the warrants held by the Company.  

Following completion of the Transaction, the Company owns an aggregate of 6,381,601 PUR Common Shares and warrants to acquire an aggregate of 2,876,335 PUR Common Shares, representing approximately 9.42% of the outstanding PUR Common Shares on a non-diluted basis and approximately 13.11% of the outstanding PUR Common Shares on a partially-diluted basis assuming exercise of all of the warrants held by the Company (before giving effect to the conversion of the Compressed Shares). Assuming the conversion of all of the issued and outstanding Compressed Shares into PUR Common Shares, the PUR Common Shares and warrants held by the Company represent approximately 8.09% of the PUR Common Shares on a non-diluted basis and approximately 11.32% of the outstanding PUR Common Shares on partially-diluted basis assuming exercise of the warrants held by the Company.

The securities of PUR held by IsoEnergy are held for investment purposes. Although IsoEnergy has no current plans with respect to the securities, depending on market conditions, general economic and industry conditions, trading prices of PUR’s securities, PUR’s business, financial condition and prospects and/or other relevant factors, IsoEnergy may develop such plans or intentions in the future and, at such time, may from time to time acquire additional securities, dispose of some or all of the existing or additional securities or may continue to hold securities of PUR.

This news release is issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, which also requires an early warning report to be filed with the applicable securities regulators containing additional information with respect to the foregoing matters. A copy of the early warning report of IsoEnergy will be available under PUR’s profile on SEDAR+ at www.sedarplus.ca. IsoEnergy’s registered office is located at 217 Queen Street West, Toronto, ON M5V 0R2.

About IsoEnergy Ltd.

IsoEnergy (NYSE American: ISOU) (TSX: ISO) is a leading, globally diversified uranium company with substantial current and historical mineral resources in top uranium mining jurisdictions of Canada, the U.S. and Australia at varying stages of development, providing near-, medium- and long-term leverage to rising uranium prices. IsoEnergy is currently advancing its Larocque East project in Canada’s Athabasca basin, which is home to the Hurricane deposit, boasting the world’s highest-grade indicated uranium mineral resource.

IsoEnergy also holds a portfolio of permitted past-producing, conventional uranium and vanadium mines in Utah with a toll milling arrangement in place with Energy Fuels. These mines are currently on standby, ready for rapid restart as market conditions permit, positioning IsoEnergy as a near-term uranium producer.

X: @IsoEnergyLtd

www.isoenergy.ca


Cautionary Statement Regarding Forward-Looking Information

This press release contains forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation (collectively, referred to as “forward-looking information”). Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. These forward-looking statements or information may relate to statements with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, including, without limitation, the Company’s potential plans with respect to the securities of PUR. Generally, but not always, forward-looking information and statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or the negative connotation thereof or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof.

Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management at the time, are inherently subject to business, market and economic risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Such assumptions include, but are not limited to, assumptions that the results of planned exploration activities are as anticipated; the anticipated mineralization of IsoEnergy’s projects being consistent with expectations and the potential benefits from such projects and any upside from such projects; the price of uranium; that general business and economic conditions will not change in a materially adverse manner; that financing will be available if and when needed and on reasonable terms; that third party contractors, equipment and supplies and governmental and other approvals required to conduct the Company’s planned activities will be available on reasonable terms and in a timely manner. Although IsoEnergy has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information.

Such statements represent the current views of IsoEnergy with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by IsoEnergy, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Risks and uncertainties include, but are not limited to the following: negative operating cash flow and dependence on third party financing; uncertainty of additional financing; no known mineral reserves; aboriginal title and consultation issues; reliance on key management and other personnel; actual results of exploration activities being different than anticipated; changes in exploration programs based upon results; availability of third party contractors; availability of equipment and supplies; failure of equipment to operate as anticipated; accidents, effects of weather and other natural phenomena; other environmental risks; changes in laws and regulations; regulatory determinations and delays; stock market conditions generally; demand, supply and pricing for uranium; other risks associated with the mineral exploration industry, and general economic and political conditions in Canada, the United States and other jurisdictions where the Company conducts business. Other factors which could materially affect such forward-looking information are described in the risk factors in IsoEnergy’s most recent annual management’s discussion and analysis and annual information form and IsoEnergy’s other filings with the securities regulators which are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and and on EDGAR at www.sec.gov. IsoEnergy does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/isoenergy-acquires-additional-securities-in-premier-american-uranium-inc-302650896.html

SOURCE IsoEnergy Ltd.

SOLAI Limited Announces Results of Extraordinary General Meeting

PR Newswire

AKRON, Ohio, Dec. 30, 2025 /PRNewswire/ — SOLAI Limited (NYSE: SLAI) (previously traded under “BTCM”) (“SOLAI” or the “Company”), a leading technology-driven cryptocurrency infrastructure company, today announced the results of its extraordinary general meeting of shareholders (the “EGM”) held on December 29, 2025.

At the EGM, the shareholders of the Company passed the resolution increasing the authorised share capital of the Company to US$1,940,000 divided into 38,399,870,000 Class A Ordinary Shares of a nominal or par value of US$0.00005 each, 65,000 Class A Preference Shares of a nominal or par value of US$0.00005 each, 65,000 Class A II Preference Shares of a nominal or par value of US$0.00005 each, and 400,000,000 Class B Ordinary Shares of a nominal or par value of US$0.00005 each, by the creation of 30,000,000,000 Class A Ordinary Shares of a nominal or par value of US$0.00005 each.

About SOLAI Limited

SOLAI Limited (previously known as “BIT Mining Limited”) (NYSE: SLAI) (previously traded under “BTCM”), is a technology-driven cryptocurrency infrastructure company expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins and payment infrastructure, and Solana treasury and staking operations — supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. By leveraging its blockchain and data infrastructure expertise, SOLAI aims to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.

For more information:

SOLAI Limited
[email protected]
ir.solai.com
www.solai.com 

Piacente Financial Communications
Brandi Piacente
Tel: +1 (212) 481-2050
Email: [email protected]

Cision View original content:https://www.prnewswire.com/news-releases/solai-limited-announces-results-of-extraordinary-general-meeting-302650579.html

SOURCE SOLAI Limited

First Citizens BancShares, Inc. Announces Date of Fourth Quarter 2025 Earnings Call

PR Newswire

RALEIGH, N.C., Dec. 30, 2025 /PRNewswire/ — First Citizens BancShares, Inc. (“BancShares”) (NASDAQ: FCNCA) today announced that it will report its financial results for the quarter ended December 31, 2025, before the U.S. financial markets open on Friday, January 23, 2026.

A conference call and webcast will be held to discuss BancShares’ financial results at 9 a.m. Eastern time on the same day. The conference call and webcast may contain forward-looking statements and other material information.

To pre-register for the call via webcast (recommended), please visit: https://events.q4inc.com/attendee/667859194. After registering, a confirmation email will be sent with a calendar reminder attachment and webcast details.

To join by telephone on the day of the call, please dial:
North America: 1-833-470-1428
All other locations: 1-929-526-1599
Access code: 837161

The investor presentation, along with the link to the webcast, will be available on the company’s website at ir.firstcitizens.com prior to the call start time. After the event, a replay of the call will also be available on the website via webcast.

About First Citizens BancShares, Inc.

First Citizens BancShares, Inc. (NASDAQ: FCNCA), a top 20 U.S. financial institution with more than $200 billion in assets and a member of the Fortune 500TM, is the financial holding company for First-Citizens Bank & Trust Company (“First Citizens Bank”). Headquartered in Raleigh, N.C., First Citizens Bank has built a unique legacy of strength, stability and long-term thinking that has spanned generations. First Citizens offers an array of general banking services including a network of branches and offices nationwide; commercial banking expertise delivering best-in-class lending, leasing and other financial services coast to coast; innovation banking serving businesses at every stage; and a nationwide direct bank. Discover more at firstcitizens.com.

Contact:     

Deanna Hart                

Angela English

Investor Relations        

Corporate Communications

919-716-2137              

803-931-1854

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/first-citizens-bancshares-inc-announces-date-of-fourth-quarter-2025-earnings-call-302650841.html

SOURCE First Citizens BancShares, Inc.

Profound Medical Corp. Announces Closing of Private Placement

TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private placement of common shares to Canadian investors (the “Offering”).

Pursuant to the Offering, the Company issued an aggregate of 921,428 common shares at a price of US$7.00 per common share, for aggregate gross proceeds of approximately US$6.45 million.

The common shares sold pursuant to the Offering are subject to a hold period of four months plus one day from the closing date of the Offering under Canadian securities laws.

The Company intends to use the net proceeds from the Offering for expansion of its sales and marketing, working capital, research and development, strategic transactions and general corporate purposes.

The securities being offered under the Offering have not been registered under the U.S. Securities Act, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws. The Company has agreed to file a registration statement with the U.S. Securities and Exchange Commission registering the resale of the common shares issued in the private placement within four months from the closing date of the Offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Company’s securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

About Profound Medical Corp.

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, AI-enhanced planning, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA Procedure™, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (“BPH”); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. The TULSA Procedure employs real-time MR guidance for precision to preserve patients’ urinary continence and sexual function, while killing the targeted prostate tissue via precise sound absorption technology that gently heats it to 55-57°C. TULSA is an incision- and radiation-free “one-and-done” procedure performed in a single session that takes a few hours. Virtually all prostate shapes and sizes can be safely, effectively, and efficiently treated with TULSA. There is no bleeding associated with the procedure; no hospital stay is required; and most TULSA patients report quick recovery to their normal routine. TULSA-PRO is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (“FDA”).

Profound is also commercializing Sonalleve®, an innovative therapeutic platform that is CE marked for the treatment of uterine fibroids, adenomyosis, pain palliation of bone metastases, desmoid tumors and osteoid osteoma. Sonalleve has also been approved by the China National Medical Products Administration for the non-invasive treatment of uterine fibroids and has FDA approval under a Humanitarian Device Exemption for the treatment of osteoid osteoma. Profound is in the early stages of exploring additional potential treatment markets for Sonalleve where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.

Forward-Looking Statements

This release includes forward-looking statements regarding Profound and its business which may include, but is not limited to, statements relating to the Company’s anticipated use of proceeds from the Offering and the intended registration of the common shares. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of Profound. The forward-looking events and circumstances discussed in this release, may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company. Although Profound has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Other factors and risks that may cause actual results to differ materially from those set out in the forward-looking statements are described in Profound’s Annual Report on Form 10-K and other filings made with U.S. and Canadian securities regulators, available at www.sedarplus.ca and www.sec.gov. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Profound undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, other than as required by law.

For further information, please contact:

Stephen Kilmer
Investor Relations
[email protected]
T: 647.872.4849



Saia to Announce Fourth Quarter 2025 Results on February 10, 2026

JOHNS CREEK, Ga., Dec. 30, 2025 (GLOBE NEWSWIRE) — Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, announced that it will release its quarterly financial results before the market opens on Tuesday, February 10th. Saia management will host a conference call to discuss the results later that morning at 10:00 a.m. Eastern Time.

To participate in the call, please dial 1-833-890-5317 and request to join the Saia, Inc. call. Callers should dial in five to ten minutes in advance of the conference call. This call will be webcast live via the company website at https://www.saia.com/about-us/investor-relations/financial-releases. A replay of the call will be offered two hours after the completion of the call through March 10, 2026 at 11:59 P.M. Eastern Time. The replay will be available by dialing 1-855-669-9658 referencing conference ID #3759658.

Saia, Inc. (Nasdaq: SAIA) offers customers a wide range of less-than-truckload, non-asset truckload, expedited and logistics services. With headquarters in Georgia, Saia LTL Freight operates 213 terminals with national service. For more information on Saia, Inc. visit the Investor Relations section at https://www.saia.com/about-us/investor-relations

CONTACT: Saia, Inc.
  Matthew Batteh
Executive Vice President and Chief Financial Officer
[email protected]
   

        



Equity Bancshares, Inc. Will Announce Fourth Quarter 2025 Results on January 21, 2026

Equity Bancshares, Inc. Will Announce Fourth Quarter 2025 Results on January 21, 2026

WICHITA, Kan–(BUSINESS WIRE)–
Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its fourth quarter financial results on Wednesday, January 21, 2026, with a press release issued after market close.

Equity Chairman and Chief Executive Officer Brad Elliott and Chief Financial Officer Chris Navratil will hold a conference call and webcast to discuss earnings results on Thursday, January 22, 2026 at 10 a.m. eastern time or 9 a.m. central time.

Those wishing to participate in the conference call should call the applicable number below and reference the Access Code below.

United States (Local): +1 646 844 6383

United States (Toll-Free): +1 833 470 1428

Global Dial-In Numbers

Access Code: 962739

To eliminate wait times, conference call participants may pre-register using this registration link. After registering, a confirmation with access details will be sent via email.

A replay of the call and webcast will be available two hours following the close of the call until February 5, 2026, accessible at investor.equitybank.com. Webcast URL: https://events.q4inc.com/attendee/528508490

About Equity Bancshares, Inc.

Equity Bancshares, Inc. is the holding company for Equity Bank, offering a full range of financial solutions, including commercial loans, consumer banking, mortgage loans, trust and wealth management services and treasury management services, while delivering the high-quality, relationship-based customer service of a community bank. Equity’s common stock is traded on the New York Stock Exchange under the symbol “EQBK.” Learn more at www.equitybank.com.

Special Note Concerning Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements reflect the current views of Equity’s management with respect to, among other things, future events and Equity’s financial performance. These statements are often, but not always, made through the use of words or phrases such as “may,” “should,” “could,” “predict,” “potential,” “believe,” “will likely result,” “expect,” “continue,” “will,” “anticipate,” “seek,” “estimate,” “intend,” “plan,” “project,” “forecast,” “goal,” “target,” “would” and “outlook,” or the negative variations of those words or other comparable words of a future or forward-looking nature. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about Equity’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond Equity’s control. Accordingly, Equity cautions you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although Equity believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from Equity’s expectations include competition from other financial institutions and bank holding companies; the effects of and changes in trade, monetary and fiscal policies and laws, including interest rate policies of the Federal Reserve Board; changes in the demand for loans; fluctuations in value of collateral and loan reserves; inflation, interest rate, market and monetary fluctuations; changes in consumer spending, borrowing and savings habits; and acquisitions and integration of acquired businesses; and similar variables. The foregoing list of factors is not exhaustive.

For discussion of these and other risks that may cause actual results to differ from expectations, please refer to “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors” in Equity’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 7, 2025, and any updates to those risk factors set forth in Equity’s subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. If one or more events related to these or other risks or uncertainties materialize, or if Equity’s underlying assumptions prove to be incorrect, actual results may differ materially from what Equity anticipates. Accordingly, you should not place undue reliance on any such forward-looking statements. Any forward-looking statement speaks only as of the date on which it is made, and Equity does not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New risks and uncertainties arise from time to time and it is not possible for us to predict those events or how they may affect us. In addition, Equity cannot assess the impact of each factor on Equity’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements, expressed or implied, included in this press release are expressly qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that Equity or persons acting on Equity’s behalf may issue.

Media Contact:

Russell Colburn

Public Relations & Communications Manager

Equity Bancshares, Inc.

(913) 583-8011

[email protected]

Investor Contact:

Brian J. Katzfey

VP, Director of Corporate Development and Investor Relations

Equity Bancshares, Inc.

(316) 858-3128

[email protected]

KEYWORDS: United States North America Kansas

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo